Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Discovery Grants Program - Individual

University of Calgary

$40,000.00

Synthesis of glycoconjugates to elicit carbohydrate-specific immune responses and enhance molecular recognitions

EF 2010-11

Résumé
Carbohydrates are ubiquitous and implicated in all cell-cell communications. Our research interests are to develop new methodologies and apply recent advances in carbohydrate chemistry, molecular biology and supramolecular chemistry to the design and synthesis of novel analogs related to bioactive carbohydrates as well as to the understanding of relevant biorecognition mechanisms. Two objectives are pursued: the first is to prepare carbohydrate-protein conjugates (vaccines) capable of stimulating hosts to generate long-lasting immune responses; the second objective is to design and synthesize carbohydrate based ligands for use as inhibitors capable of competitively binding to proteins such as enzymes, toxins, lectins, in order to block undesired recognitions. In the context of our first objective, our research can lead to the production of preventive vaccines against bacterial infections, or to the generation of therapeutic antibodies with potential to selectively eliminate malignant tumour cells. In the context of the second objective, if the undesired interaction is from an enzyme's recognitions of a substrate, our research can generate high affinity ligands capable of binding to the enzyme's active site, leading to a downregulation of enzyme's efficiency to produce undesired molecules; if the undesired interaction is directly linked to the attachment of pathogens, such toxins to carbohydrates present on the surface of host cells, our research could lead to the generation of high affinity carbohydrates based therapeutics capable of preventing the pathogenic attachment. Based on the concepts outlined above and on results obtained during past three years, we propose to conduct research in the following three areas: the first is related to the chemistry of alpha(2,8)-linked oligosialosides and their immunochemistry; the second is related to the development of synthetic methodology for KDO glycosides and the third is to investigate the potential of utilizing multi-substituted cyclodextrins as building blocks to generate novel cyclodextrin-based supramolecular systems capable of engaging protein binding sites across large distances.
Programme
Discovery Grants Program - Individual
Bénéficiaire
Emplacement
Alberta, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data

Tel que publié

Application id
341532-2010
Name nom
Ling, ChangChun
Department département
Chemistry
Organization id
11
Institution établissement
University of Calgary
Province en
Alberta
Province fr
Alberta
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2010
Competition year année de concours
2010
Award amount
40000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
1504
Committee name en
Chemistry
Committee name fr
Chimie
Area of application code
1200
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Advancement of knowledge
Area of application fr
Avancement des connaissances
Research subject code
3705
Research subject group en
Organic chemistry
Research subject group fr
Chimie organique
Research subject en
Bio-organic chemistry
Research subject fr
Chimie bio-organique
Partie
1
Nb partie
1
Application title
Synthesis of glycoconjugates to elicit carbohydrate-specific immune responses and enhance molecular recognitions
Keyword
NSERC
Application summary
Carbohydrates are ubiquitous and implicated in all cell-cell communications. Our research interests are to develop new methodologies and apply recent advances in carbohydrate chemistry, molecular biology and supramolecular chemistry to the design and synthesis of novel analogs related to bioactive carbohydrates as well as to the understanding of relevant biorecognition mechanisms. Two objectives are pursued: the first is to prepare carbohydrate-protein conjugates (vaccines) capable of stimulating hosts to generate long-lasting immune responses; the second objective is to design and synthesize carbohydrate based ligands for use as inhibitors capable of competitively binding to proteins such as enzymes, toxins, lectins, in order to block undesired recognitions. In the context of our first objective, our research can lead to the production of preventive vaccines against bacterial infections, or to the generation of therapeutic antibodies with potential to selectively eliminate malignant tumour cells. In the context of the second objective, if the undesired interaction is from an enzyme's recognitions of a substrate, our research can generate high affinity ligands capable of binding to the enzyme's active site, leading to a downregulation of enzyme's efficiency to produce undesired molecules; if the undesired interaction is directly linked to the attachment of pathogens, such toxins to carbohydrates present on the surface of host cells, our research could lead to the generation of high affinity carbohydrates based therapeutics capable of preventing the pathogenic attachment. Based on the concepts outlined above and on results obtained during past three years, we propose to conduct research in the following three areas: the first is related to the chemistry of alpha(2,8)-linked oligosialosides and their immunochemistry; the second is related to the development of synthetic methodology for KDO glycosides and the third is to investigate the potential of utilizing multi-substituted cyclodextrins as building blocks to generate novel cyclodextrin-based supramolecular systems capable of engaging protein binding sites across large distances.